Figure 5. Effect of HLJG0701 on scopolamine-induced spatial memory impairment. (A) Escape latency to find the platform during the training stages. (B) The time spent in the target quadrant of the probe trial. Mice in different groups were administered with saline (control, CON), scopolamine (1 mg/kg, i.p., SPL-G), HLJG0701 (150 mg/kg, HG-150; 300 mg/kg, HG-300; 600 mg/kg, HG-600, p.o.) and tetrahydroaminoacridine (10 mg/kg, p.o., THA-10) 6 times per week for 5 weeks. Training trial sessions were conducted for 5 days and retention times were measured on day 6. Data are expressed as the mean±SD (n=8). Means with different superscripts are significantly different (P<0.05).
